首页 > 最新文献

Urologie最新文献

英文 中文
AUO.
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-11-01 DOI: 10.1007/s00120-025-02704-4
{"title":"AUO.","authors":"","doi":"10.1007/s00120-025-02704-4","DOIUrl":"https://doi.org/10.1007/s00120-025-02704-4","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"64 11","pages":"1246-1247"},"PeriodicalIF":0.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mitteilungen der DGU. DGU通讯。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-11-01 DOI: 10.1007/s00120-025-02709-z
{"title":"Mitteilungen der DGU.","authors":"","doi":"10.1007/s00120-025-02709-z","DOIUrl":"https://doi.org/10.1007/s00120-025-02709-z","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"64 11","pages":"1221-1232"},"PeriodicalIF":0.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145409650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Surgical techniques to improve continence after robot-assisted laparoscopic radical prostatectomy based on video-anatomy-a review]. [基于视频解剖的机器人辅助腹腔镜根治性前列腺切除术后改善尿失禁的手术技术综述]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-11-01 Epub Date: 2025-06-16 DOI: 10.1007/s00120-025-02627-0
Jens Rassweiler, Sara Sander

Background: Since robot-assisted laparoscopic prostatectomy (RALP) has become widely accepted in German-speaking countries, there needs to be an agreement on the most efficient surgical techniques. This should be based on the video-anatomy of the prostate and a summary of the actual literature.

Materials and methods: Based on video material of different surgical techniques, a systematic literature search in PubMed has been performed focusing on preservation of continence and minimal rates of positive margins. This is based on the anatomy of the male pelvis applying a standard nomenclature. The original 3825 publications could be reduced to 604 articles according to the inclusion criteria (randomized controlled trials, meta-analyses, systematic reviews, and clinical studies). When expanding the search to encompass individual operation techniques, we identified 27 relevant articles.

Results: Crucial surgical details include preserving the levator fascia, the puboprostatic collar, a long urethral stump with protection of the urethral lissosphincter and posteriorly reconstruction of the rectourethralis with the prostatovesical muscle. Fascial preservation for the levator ani muscle results in 1‑year continence between 78.0 and 98.3%, preservation of the puboprostatic collar and detrusor apron between 95.6 and 100%, maximal functional urethral length between 90.5 and 97.5%. Posterior reconstruction leads to a 3-month continence between 92.3 and 96.9%. Preserving the Retzius' space and thus the total anterior sphincter apparatus results in 1‑year continence of 95.8%; however, it is associated with a higher rate of positive surgical margins (14-42 vs. 10-29%).

Conclusion: Based on the increase of knowledge and the feasibility to translate this into novel surgical techniques, the continence rates could be significantly improved. This includes approaches to spare anatomical structures of the sphincter apparatus, such as preservation of the levator fascia, the puboprostatic collar, the urethral lissosphincter, but also reconstructive techniques, such as posterior reconstruction of the vesicoprostatic and rectourethralis muscle. Demanding techniques, such as the Retzius-sparing approach result in higher continence rates, but are also associated with a higher rate of surgical margins.

背景:由于机器人辅助腹腔镜前列腺切除术(RALP)在德语国家已被广泛接受,因此需要对最有效的手术技术达成一致。这应该基于前列腺的视频解剖和实际文献的总结。材料和方法:基于不同手术技术的视频资料,在PubMed上进行了系统的文献检索,重点是保留失禁和最小阳性边缘率。这是基于男性骨盆的解剖结构,采用标准的命名法。根据纳入标准(随机对照试验、荟萃分析、系统评价和临床研究),最初的3825篇出版物可以减少到604篇。当将搜索范围扩大到包含单个操作技术时,我们确定了27篇相关文章。结果:关键的手术细节包括保留提肌筋膜、耻骨前列腺领、保护尿道舌括约肌的长尿道残端和前列腺膀胱肌后方重建直肠尿道。筋膜保留提肛肌的1年尿失禁率在78.0 ~ 98.3%之间,耻骨前列腺环和逼尿肌围在95.6 ~ 100%之间,最大功能尿道长度在90.5% ~ 97.5%之间。后路重建导致3个月的尿失禁率在92.3 - 96.9%之间。保留Retzius间隙,从而保留整个前括约肌,1年尿失禁率为95.8%;然而,它与较高的手术切缘阳性率相关(14- 42% vs. 10-29%)。结论:基于知识的增加和将其转化为新的手术技术的可行性,可以显著提高失禁率。这包括保留括约肌器官解剖结构的方法,如保留提肌筋膜、耻骨前列腺领、尿道舌括约肌,也包括重建技术,如膀胱前列腺肌和直尿道肌的后侧重建。要求较高的技术,如Retzius-sparing入路导致较高的尿失禁率,但也与较高的手术切缘率相关。
{"title":"[Surgical techniques to improve continence after robot-assisted laparoscopic radical prostatectomy based on video-anatomy-a review].","authors":"Jens Rassweiler, Sara Sander","doi":"10.1007/s00120-025-02627-0","DOIUrl":"10.1007/s00120-025-02627-0","url":null,"abstract":"<p><strong>Background: </strong>Since robot-assisted laparoscopic prostatectomy (RALP) has become widely accepted in German-speaking countries, there needs to be an agreement on the most efficient surgical techniques. This should be based on the video-anatomy of the prostate and a summary of the actual literature.</p><p><strong>Materials and methods: </strong>Based on video material of different surgical techniques, a systematic literature search in PubMed has been performed focusing on preservation of continence and minimal rates of positive margins. This is based on the anatomy of the male pelvis applying a standard nomenclature. The original 3825 publications could be reduced to 604 articles according to the inclusion criteria (randomized controlled trials, meta-analyses, systematic reviews, and clinical studies). When expanding the search to encompass individual operation techniques, we identified 27 relevant articles.</p><p><strong>Results: </strong>Crucial surgical details include preserving the levator fascia, the puboprostatic collar, a long urethral stump with protection of the urethral lissosphincter and posteriorly reconstruction of the rectourethralis with the prostatovesical muscle. Fascial preservation for the levator ani muscle results in 1‑year continence between 78.0 and 98.3%, preservation of the puboprostatic collar and detrusor apron between 95.6 and 100%, maximal functional urethral length between 90.5 and 97.5%. Posterior reconstruction leads to a 3-month continence between 92.3 and 96.9%. Preserving the Retzius' space and thus the total anterior sphincter apparatus results in 1‑year continence of 95.8%; however, it is associated with a higher rate of positive surgical margins (14-42 vs. 10-29%).</p><p><strong>Conclusion: </strong>Based on the increase of knowledge and the feasibility to translate this into novel surgical techniques, the continence rates could be significantly improved. This includes approaches to spare anatomical structures of the sphincter apparatus, such as preservation of the levator fascia, the puboprostatic collar, the urethral lissosphincter, but also reconstructive techniques, such as posterior reconstruction of the vesicoprostatic and rectourethralis muscle. Demanding techniques, such as the Retzius-sparing approach result in higher continence rates, but are also associated with a higher rate of surgical margins.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1173-1186"},"PeriodicalIF":0.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12575472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144303081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Adjuvant immunotherapy with pembrolizumab for renal cell carcinoma-is the new standard of care cost-effective?? : A health economic analysis]. pembrolizumab辅助免疫治疗肾细胞癌——新的治疗标准是否具有成本效益?[健康经济分析]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-11-01 Epub Date: 2025-07-10 DOI: 10.1007/s00120-025-02632-3
Sarah Katharina Assiba Weiß, Carsten Lange, Nicole Hübscher, Abdullah Al Hasan, Steffen Hallmann, Tobias Klatte

Background: Adjuvant pembrolizumab decreases the risk of recurrence and prolongs survival after surgery for high-risk clear cell renal cell carcinoma. Cost-effectiveness analyses evaluate therapy associated risks, toxicity, quality of life, costs of therapies and follow-up regimens and represent an essential adjunct for the evaluation of new therapies. At present, there is no cost effectiveness analysis for adjuvant pembrolizumab within the German healthcare system.

Methods: A Markov model was used to evaluate cost-effectiveness. The impact of variables on the cost-effectiveness of therapy were investigated with one-way deterministic and probabilistic sensitivity analysis and thresholds were determined.

Results: The adjuvant treatment with pembrolizumab was cost-effective over a 5-year period, with an ICER (incremental cost-effectiveness ratio) of 68,278 €/QALY (quality-adjusted life year) assuming a WTP (willingness to pay) threshold of 100,000 €/QALY.

Conclusion: Adjuvant treatment in high-risk patients with pembrolizumab has been shown to be cost-effective when applied within the German health system. It should therefore be offered to all patients with an increased risk for recurrence after curative surgery.

背景:辅助派姆单抗可降低高风险透明细胞肾细胞癌术后复发风险,延长生存期。成本效益分析评估治疗相关的风险、毒性、生活质量、治疗成本和随访方案,是评估新疗法的重要辅助手段。目前,在德国医疗保健系统中没有对辅助派姆单抗的成本效益分析。方法:采用马尔可夫模型进行成本-效果评价。采用单向确定性和概率敏感性分析研究变量对治疗成本-效果的影响,并确定阈值。结果:pembrolizumab辅助治疗在5年期间具有成本效益,ICER(增量成本-效果比)为68,278 €/QALY(质量调整生命年),假设WTP(支付意愿)阈值为100,000 €/QALY。结论:在德国卫生系统中应用派姆单抗辅助治疗高风险患者已被证明具有成本效益。因此,治疗性手术后复发风险增加的所有患者都应接受这种治疗。
{"title":"[Adjuvant immunotherapy with pembrolizumab for renal cell carcinoma-is the new standard of care cost-effective?? : A health economic analysis].","authors":"Sarah Katharina Assiba Weiß, Carsten Lange, Nicole Hübscher, Abdullah Al Hasan, Steffen Hallmann, Tobias Klatte","doi":"10.1007/s00120-025-02632-3","DOIUrl":"10.1007/s00120-025-02632-3","url":null,"abstract":"<p><strong>Background: </strong>Adjuvant pembrolizumab decreases the risk of recurrence and prolongs survival after surgery for high-risk clear cell renal cell carcinoma. Cost-effectiveness analyses evaluate therapy associated risks, toxicity, quality of life, costs of therapies and follow-up regimens and represent an essential adjunct for the evaluation of new therapies. At present, there is no cost effectiveness analysis for adjuvant pembrolizumab within the German healthcare system.</p><p><strong>Methods: </strong>A Markov model was used to evaluate cost-effectiveness. The impact of variables on the cost-effectiveness of therapy were investigated with one-way deterministic and probabilistic sensitivity analysis and thresholds were determined.</p><p><strong>Results: </strong>The adjuvant treatment with pembrolizumab was cost-effective over a 5-year period, with an ICER (incremental cost-effectiveness ratio) of 68,278 €/QALY (quality-adjusted life year) assuming a WTP (willingness to pay) threshold of 100,000 €/QALY.</p><p><strong>Conclusion: </strong>Adjuvant treatment in high-risk patients with pembrolizumab has been shown to be cost-effective when applied within the German health system. It should therefore be offered to all patients with an increased risk for recurrence after curative surgery.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1164-1172"},"PeriodicalIF":0.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144609685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BvDU Kurz notiert. BvDU简短注释。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-11-01 DOI: 10.1007/s00120-025-02706-2
{"title":"BvDU Kurz notiert.","authors":"","doi":"10.1007/s00120-025-02706-2","DOIUrl":"https://doi.org/10.1007/s00120-025-02706-2","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":"64 11","pages":"1233-1235"},"PeriodicalIF":0.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145408959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Health impacts of climate change and role of the health sector in mitigating carbon emissions. German version]. [气候变化对健康的影响以及卫生部门在减少碳排放方面的作用。德国版)。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-11-01 Epub Date: 2025-10-10 DOI: 10.1007/s00120-025-02699-y
E Rothwell, Jonny Groome

The climate crisis has been identified as the largest threat to human health; paradoxically, the healthcare sector is responsible for 5% of the global greenhouse gas emissions that are driving this crisis. These emissions are largely due to carbon-intensive facilities, energy use, complex global supply chains, transportation and pharmaceuticals. In its role of safeguarding the health of both current and future populations, the healthcare sector must take actions to minimise its environmental impact. Strategies for emission reduction include sustainable infrastructure, clinical practice innovations, and procurement and supply chain reform. This article aims to examine current evidence on the health impacts of climate change and explore strategies through which the healthcare sector can reduce its environmental impact while continuing to deliver high-quality care.

气候危机已被确定为对人类健康的最大威胁;矛盾的是,医疗保健行业的温室气体排放量占全球温室气体排放量的5%,而正是这些温室气体导致了这场危机。这些排放主要是由于碳密集型设施、能源使用、复杂的全球供应链、运输和制药。在保护当前和未来人口健康的作用下,医疗保健部门必须采取行动,尽量减少其对环境的影响。减排战略包括可持续基础设施、临床实践创新以及采购和供应链改革。本文旨在研究气候变化对健康影响的现有证据,并探讨医疗保健部门在继续提供高质量医疗服务的同时减少其对环境影响的策略。
{"title":"[Health impacts of climate change and role of the health sector in mitigating carbon emissions. German version].","authors":"E Rothwell, Jonny Groome","doi":"10.1007/s00120-025-02699-y","DOIUrl":"10.1007/s00120-025-02699-y","url":null,"abstract":"<p><p>The climate crisis has been identified as the largest threat to human health; paradoxically, the healthcare sector is responsible for 5% of the global greenhouse gas emissions that are driving this crisis. These emissions are largely due to carbon-intensive facilities, energy use, complex global supply chains, transportation and pharmaceuticals. In its role of safeguarding the health of both current and future populations, the healthcare sector must take actions to minimise its environmental impact. Strategies for emission reduction include sustainable infrastructure, clinical practice innovations, and procurement and supply chain reform. This article aims to examine current evidence on the health impacts of climate change and explore strategies through which the healthcare sector can reduce its environmental impact while continuing to deliver high-quality care.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"1130-1138"},"PeriodicalIF":0.4,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12575500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Additional comments on HPV vaccination for boys]. [关于男孩接种HPV疫苗的补充评论]。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-10-31 DOI: 10.1007/s00120-025-02723-1
Gerhard Zöller
{"title":"[Additional comments on HPV vaccination for boys].","authors":"Gerhard Zöller","doi":"10.1007/s00120-025-02723-1","DOIUrl":"https://doi.org/10.1007/s00120-025-02723-1","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145422969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[HPV vaccination: economically sensible and medically beneficial]. HPV疫苗接种:经济上合理,医学上有益。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-10-31 DOI: 10.1007/s00120-025-02724-0
Peter Schneede
{"title":"[HPV vaccination: economically sensible and medically beneficial].","authors":"Peter Schneede","doi":"10.1007/s00120-025-02724-0","DOIUrl":"https://doi.org/10.1007/s00120-025-02724-0","url":null,"abstract":"","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145422979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Infectious bacterial symphysitis (purulent infection of the pubic symphysis) in a urological setting-a descriptive study and treatment algorithm]. 泌尿科的感染性细菌性联合炎(耻骨联合化脓性感染)——描述性研究和治疗方法。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-10-30 DOI: 10.1007/s00120-025-02715-1
F-J Dally, M A Rupp Pardos, D Buergy, F Giordano, N Westhoff, S Gravius, U Obertacke, F Bludau

Background: Purulent infection of the pubic symphysis (infectious bacterial symphysitis, IBS) is a rare but serious disease of the symphysis and parasymphyseal structures. It can develop following surgery, interventions in the lower urinary tract, or pelvic radiation therapy.

Objective: We report on one of the largest urological cohorts with post-therapeutic IBS, with the aim of increasing awareness for this severe condition and optimizing diagnosis and treatment.

Methods: We conducted a descriptive retrospective data analysis at a university hospital over the years 2018-2022. Of the total collective, 25 patients were treated for underlying urological diseases and are part of this subgroup analysis.

Results: Of the 25 patients with IBS, 24 were suffering from or had been treated for urological malignancies (19/24 [79%] prostate cancer; 5/24 [21%] urothelial cancer). Two patients had been treated for nonmalignant urological diseases. The average interval between surgery or intervention in the lower urinary tract due to the underlying urological disease and the diagnosis of IBS was 73.9 months (SD ± 55.7 months). Relevant fistula formations were detected in 14/25 (56%) cases, most frequently between bladder and symphysis (8/14, 57%). Of the 25 patients, 11 (58%) could be treated conservatively, while 14 (56%) had required complex, interdisciplinary, reconstructive, and, above all, multiple surgical procedures.

Conclusion: Purulent infection of the pubic symphysis is a severe clinical condition that can occur during-and even years after-urological and uro-oncological treatments. This study illustrates the importance of ruling out IBS even years after urological disease or surgery or interventions in the lower urinary tract. Interdisciplinary treatment involving colleagues from orthopedic and trauma surgery should always be sought, as should treatment in a center with the appropriate experience, case numbers, and infrastructure. As diagnosis and treatment are demanding, creation of an interdisciplinary guideline could be useful. We present an algorithm which includes diagnostic steps and rational therapeutic options.

背景:耻骨联合化脓性感染(感染性细菌性联合炎,IBS)是一种罕见但严重的耻骨联合和副淋巴结构疾病。它可以在手术、下尿路干预或盆腔放射治疗后发展。目的:我们报道了治疗后IBS最大的泌尿科队列之一,目的是提高对这种严重疾病的认识并优化诊断和治疗。方法:对某大学附属医院2018-2022年的临床资料进行描述性回顾性分析。在所有患者中,有25名患者接受了泌尿系统基础疾病治疗,属于本亚组分析的一部分。结果:25例IBS患者中,有24例患有或曾接受过泌尿系统恶性肿瘤治疗(19/24[79%]前列腺癌;5/24[21%]尿路上皮癌)。2例患者曾接受非恶性泌尿系统疾病治疗。下尿路手术或干预与诊断为IBS的平均间隔时间为73.9个月(SD ±55.7个月)。在14/25(56%)的病例中发现了相关的瘘管形成,最常见的是膀胱和联合(8/14,57%)。在25例患者中,11例(58%)可以保守治疗,而14例(56%)需要复杂的、跨学科的、重建的,最重要的是,多次手术。结论:耻骨联合化脓性感染是一种严重的临床疾病,可在泌尿外科和泌尿肿瘤治疗期间甚至数年后发生。这项研究说明了排除肠易激综合征的重要性,即使是在泌尿系统疾病或手术或下尿路干预多年后。应始终寻求骨科和创伤外科同事参与的跨学科治疗,也应在具有适当经验、病例数和基础设施的中心进行治疗。由于诊断和治疗的要求很高,创建一个跨学科的指导方针可能是有用的。我们提出了一个算法,其中包括诊断步骤和合理的治疗方案。
{"title":"[Infectious bacterial symphysitis (purulent infection of the pubic symphysis) in a urological setting-a descriptive study and treatment algorithm].","authors":"F-J Dally, M A Rupp Pardos, D Buergy, F Giordano, N Westhoff, S Gravius, U Obertacke, F Bludau","doi":"10.1007/s00120-025-02715-1","DOIUrl":"https://doi.org/10.1007/s00120-025-02715-1","url":null,"abstract":"<p><strong>Background: </strong>Purulent infection of the pubic symphysis (infectious bacterial symphysitis, IBS) is a rare but serious disease of the symphysis and parasymphyseal structures. It can develop following surgery, interventions in the lower urinary tract, or pelvic radiation therapy.</p><p><strong>Objective: </strong>We report on one of the largest urological cohorts with post-therapeutic IBS, with the aim of increasing awareness for this severe condition and optimizing diagnosis and treatment.</p><p><strong>Methods: </strong>We conducted a descriptive retrospective data analysis at a university hospital over the years 2018-2022. Of the total collective, 25 patients were treated for underlying urological diseases and are part of this subgroup analysis.</p><p><strong>Results: </strong>Of the 25 patients with IBS, 24 were suffering from or had been treated for urological malignancies (19/24 [79%] prostate cancer; 5/24 [21%] urothelial cancer). Two patients had been treated for nonmalignant urological diseases. The average interval between surgery or intervention in the lower urinary tract due to the underlying urological disease and the diagnosis of IBS was 73.9 months (SD ± 55.7 months). Relevant fistula formations were detected in 14/25 (56%) cases, most frequently between bladder and symphysis (8/14, 57%). Of the 25 patients, 11 (58%) could be treated conservatively, while 14 (56%) had required complex, interdisciplinary, reconstructive, and, above all, multiple surgical procedures.</p><p><strong>Conclusion: </strong>Purulent infection of the pubic symphysis is a severe clinical condition that can occur during-and even years after-urological and uro-oncological treatments. This study illustrates the importance of ruling out IBS even years after urological disease or surgery or interventions in the lower urinary tract. Interdisciplinary treatment involving colleagues from orthopedic and trauma surgery should always be sought, as should treatment in a center with the appropriate experience, case numbers, and infrastructure. As diagnosis and treatment are demanding, creation of an interdisciplinary guideline could be useful. We present an algorithm which includes diagnostic steps and rational therapeutic options.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Environmental sustainability in urology]. 泌尿外科的环境可持续性。
IF 0.4 4区 医学 Q4 UROLOGY & NEPHROLOGY Pub Date : 2025-10-30 DOI: 10.1007/s00120-025-02720-4
Bernd Wullich, Holger Borchers, Christian Eggersmann, Maximilian Burger, Marlene Thöne

Environmental sustainability has become increasingly important in recent years, not only in social discourse but also in the healthcare sector. The healthcare sector in Germany contributes significantly to total CO2 emissions, accounting for over 5%, and consumes roughly the same amount of resources. Areas that are particularly relevant to urology, such as pharmaceuticals, medical devices, and instrument logistics, are among the most intensive consumers of resources, alongside construction measures, the operation of clinics and practices, and food supply. In light of this, the German Society of Urology (DGU) has recognized the urgency of the situation and developed a sustainability strategy that includes all sectors of the field and aims to provide concrete perspectives for the responsible use of existing resources.

近年来,环境可持续性变得越来越重要,不仅在社会话语中,而且在医疗保健部门。德国的医疗保健行业对二氧化碳排放总量的贡献很大,占5%以上,消耗的资源数量大致相同。与泌尿外科特别相关的领域,如药品、医疗器械和仪器物流,与建筑措施、诊所和实践的运营以及食品供应一样,都是资源消耗最密集的领域。鉴于此,德国泌尿外科学会(DGU)已经认识到形势的紧迫性,并制定了一项包括该领域所有部门的可持续发展战略,旨在为负责任地使用现有资源提供具体的观点。
{"title":"[Environmental sustainability in urology].","authors":"Bernd Wullich, Holger Borchers, Christian Eggersmann, Maximilian Burger, Marlene Thöne","doi":"10.1007/s00120-025-02720-4","DOIUrl":"https://doi.org/10.1007/s00120-025-02720-4","url":null,"abstract":"<p><p>Environmental sustainability has become increasingly important in recent years, not only in social discourse but also in the healthcare sector. The healthcare sector in Germany contributes significantly to total CO<sub>2</sub> emissions, accounting for over 5%, and consumes roughly the same amount of resources. Areas that are particularly relevant to urology, such as pharmaceuticals, medical devices, and instrument logistics, are among the most intensive consumers of resources, alongside construction measures, the operation of clinics and practices, and food supply. In light of this, the German Society of Urology (DGU) has recognized the urgency of the situation and developed a sustainability strategy that includes all sectors of the field and aims to provide concrete perspectives for the responsible use of existing resources.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":""},"PeriodicalIF":0.4,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145410416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1